research reports and media, page-381

First 381 Last

Share
Profile

Follow
p0ssy

105 Posts.

17/12/19

22:25

Post #: 42019132
Share

https://www.fiftyonecapital.com/performance-media

Originally posted by ceviche: ↑

Rennie had a interview with Alan Kohler, who also has knee problems.
Rennie took Kohler through what we know, also emphasizing that a lot of AFL users were less than 30 years old.
He also did a plug for approaching local doctors on basis that all other medications had failed, and there was a case that they could make for TGA special access for which PAR make no charge.
He also mentioned that Bene Pharma are the only FDA approved producer, and they have that 20 years supply agreement.
at tail end of interview...
"
The actual compound is extracted from the bark of the European beech tree and that process of extraction is a very difficult one because there are many different molecules in the organic material. Extracting just the Pentosan, which is a five-sugar polymer, which is the backbone to the drug, is part of the art that the Germans have perfected.
....
If you just take European beech tree and try and extract out Pentosan, you will get a whole range of other compounds and those compounds may or may not be beneficial for the patient. They may have deleterious effects. Making sure that you only get the Pentosan is very important and I think the Germans have definitely perfected that.
And then you add Polysulfate and sodium to it,...
You get the Pentosan from the beech tree, it goes through a synthetic process of adding the Polysulfates and then extracting the sodium salt from that and then producing the very bottom of the process, Pentosan Polysulfate.
"

Expand

PAR Price at posting: $2.92 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WAF

West African snaffles gold intercept at 7.3 g/t in Burkina Faso

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

VCX

Vicinity buys a half share in Lakeside Joondalup Shopping Centre for $420M

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

ASX Market Open: Australian market to rise on US rally, S&P 500 and Nasdaq continue winning streak | August 20, 2024

There are more pages in this discussion • 4,024 more messages in this thread...

First 381 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 24.5¢		Change 0.015(6.52%)		Mkt cap ! $80.45M

Open	High	Low	Value	Volume
24.0¢	24.5¢	24.0¢	$25.30K	105.1K

Buyers (Bids)

No.	Vol.	Price($)
2	95585	24.0¢

Sellers (Offers)

Price($)	Vol.	No.
24.5¢	3389	1

View Market Depth

No.	Vol.	Price($)
2	95585	0.240
3	145251	0.235
9	232565	0.230
6	90050	0.225
12	237794	0.220

Price($)	Vol.	No.
0.245	3389	1
0.250	29100	2
0.255	2698	1
0.260	20555	3
0.270	13000	2

Last trade - 10.08am 20/08/2024 (20 minute delay)

PAR (ASX) Chart

research reports and media, page-381

West African snaffles gold intercept at 7.3 g/t in Burkina Faso

Fourfold skarn increase points the way to viable garnet project, says Pure

Vicinity buys a half share in Lakeside Joondalup Shopping Centre for $420M

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

ASX Market Open: Australian market to rise on US rally, S&P 500 and Nasdaq continue winning streak | August 20, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

research reports and media, page-381

Top Stories

West African snaffles gold intercept at 7.3 g/t in Burkina Faso

Fourfold skarn increase points the way to viable garnet project, says Pure

Vicinity buys a half share in Lakeside Joondalup Shopping Centre for $420M

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

ASX Market Open: Australian market to rise on US rally, S&P 500 and Nasdaq continue winning streak | August 20, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News